col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


265 Results       Page 1

 [1] 
MDPI AG: Molecules
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―30 Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins Massimo E. Maffei, Cristiano Salata, Giorgio Gribaudo
2 [GO] 2022―Nov―28 Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology Yalan Zhou, Huizhen Wang, Li Yang, Qingzhong Wang
3 [GO] 2022―Nov―28 Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2 Mateusz Kciuk, Somdutt Mujwar, Isha Rani, Kavita Munjal, Adrianna Gielecińska, Renata Kontek, Kamal Shah
4 [GO] 2022―Nov―28 Insights into the Dynamics and Binding of Two Polyprotein Substrate Cleavage Points in the Context of the SARS-CoV-2 Main and Papain-like Proteases Zainab Kemi Sanusi, Kevin Alan Lobb
5 [GO] 2022―Nov―28 Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies Mahadevamurthy Murali, Hittanahallikoppal Gajendramurthy Gowtham, Natarajamurthy Shilpa, Hemanth Kumar Naguvanahalli Krishnappa, Ana E. Ledesma, Anisha S. Jain, et al. (+13)
6 [GO] 2022―Nov―25 Isolation and In Silico Prediction of Potential Drug-like Compounds with a New Dimeric Prenylated Quinolone Alkaloid from Zanthoxylum rhetsa (Roxb.) Root Extracts Targeted against SARS-CoV-2 (Mpro) Fatema Tuz Zohora, A. T. M. Zafrul Azam, Sinthyia Ahmed, Khondaker Miraz Rahman, Mohammad A. Halim, Md. Rafi Anwar, et al. (+4)
7 [GO] 2022―Nov―22 Virtual Screening of Artemisia annua Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme Khalid Miandad, Asad Ullah, Kashif Bashir, Saifullah Khan, Syed Ainul Abideen, Bilal Shaker, et al. (+5)
8 [GO] 2022―Nov―22 Neuropeptides, New Ligands of SARS-CoV-2 Nucleoprotein, a Potential Link between Replication, Inflammation and Neurotransmission Julien Henri, Laetitia Minder, Kevin Mohanasundaram, Sébastien Dilly, Anne Goupil-Lamy, Carmelo Di Primo, Anny Slama Schwok
9 [GO] 2022―Nov―16 Essential Oils and COVID-19 Mahmoud Fahmi Elsebai, Marzough Aziz Albalawi
10 [GO] 2022―Nov―11 Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2 Abdulelah Aljuaid, Abdus Salam, Mazen Almehmadi, Soukayna Baammi, Fahad M. Alshabrmi, Mamdouh Allahyani, et al. (+5)
11 [GO] 2022―Nov―04 In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2 Elena G. Geromichalou, George D. Geromichalos
12 [GO] 2022―Nov―04 Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach Isabella Romeo, Francesca Alessandra Ambrosio, Giosuè Costa, Angela Corona, Mohammad Alkhatib, Romina Salpini, et al. (+8)
13 [GO] 2022―Nov―04 Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro Ahmed L. Alaofi, Mudassar Shahid, Mohammad Raish, Mushtaq Ahmad Ansari, Rabbani Syed, Mohd Abul Kalam
14 [GO] 2022―Nov―01 Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2 Jiewen Fu, Shuguang Liu, Qi Tan, Zhiying Liu, Jie Qian, Ting Li, et al. (+13)
15 [GO] 2022―Oct―30 Ultra-Large-Scale Screening of Natural Compounds and Free Energy Calculations Revealed Potential Inhibitors for the Receptor-Binding Domain (RBD) of SARS-CoV-2 Lisha Guo, Faryar Zafar, Nawal Moeen, Fahad M. Alshabrmi, Junqi Lin, Syed Shujait Ali, et al. (+3)
16 [GO] 2022―Oct―30 A Comprehensive In Silico Study of New Metabolites from Heteroxenia fuscescens with SARS-CoV-2 Inhibitory Activity Fahd M. Abdelkarem, Alaa M. Nafady, Ahmed E. Allam, Mahmoud A. H. Mostafa, Rwaida A. Al Haidari, Heba Ali Hassan, et al. (+6)
17 [GO] 2022―Oct―30 Homology Modeling and Molecular Dynamics-Driven Search for Natural Inhibitors That Universally Target Receptor-Binding Domain of Spike Glycoprotein in SARS-CoV-2 Variants Olha Ovchynnykova, Karina Kapusta, Natalia Sizochenko, Kostyantyn M. Sukhyy, Wojciech Kolodziejczyk, Glake A. Hill, Julia Saloni
18 [GO] 2022―Oct―26 The Antiviral Activity of Caprylic Monoglyceride against Porcine Reproductive and Respiratory Syndrome Virus In Vitro and In Vivo Luyu Yang, Jianhua Wen, Yang Zhang, Zheyan Liu, Zhipeng Luo, Lei Xu, et al. (+6)
19 [GO] 2022―Oct―18 Derivation, Functionalization of (S)-Goniothalamin from Goniothalamus wightii and Their Derivative Targets SARS-CoV-2 MPro, SPro, and RdRp: A Pharmacological Perspective Vino Palani, Santhosh Chinnaraj, Murugesh Shanmugasundaram, Arunkumar Malaisamy, Viji Maluventhen, Vijaya Anand Arumugam, et al. (+4)
20 [GO] 2022―Oct―17 Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2 Rahima Begum, A. N. M. Mamun-Or-Rashid, Tanzima Tarannum Lucy, Md. Kamruzzaman Pramanik, Bijon Kumar Sil, Nobendu Mukerjee, et al. (+3)
21 [GO] 2022―Oct―12 Elucidation of Binding Features and Dissociation Pathways of Inhibitors and Modulators in SARS-CoV-2 Main Protease by Multiple Molecular Dynamics Simulations Lei Xu, Liangxu Xie, Dawei Zhang, Xiaojun Xu
22 [GO] 2022―Oct―10 Effects of a Shift of the Signal Peptide Cleavage Site in Signal Peptide Variant on the Synthesis and Secretion of SARS-CoV-2 Spike Protein Zhikai Zhang, Xuan Wan, Xinyue Li, Chengsong Wan
23 [GO] 2022―Oct―10 The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation Radwa E. Mahgoub, Feda E. Mohamed, Lara Alzyoud, Bassam R. Ali, Juliana Ferreira, Wael M. Rabeh, et al. (+3)
24 [GO] 2022―Oct―09 Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding Mubarak A. Alamri, Muhammad Tahir ul Qamar, Alhumaidi B. Alabbas, Safar M. Alqahtani, Manal A. Alossaimi, Sikandar Azam, et al. (+2)
25 [GO] 2022―Sep―28 In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease Piyush Kashyap, Mamta Thakur, Nidhi Singh, Deep Shikha, Shiv Kumar, Poonam Baniwal, et al. (+4)
26 [GO] 2022―Sep―20 Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity Chang Liu, Tess Puopolo, Huifang Li, Ang Cai, Navindra P. Seeram, Hang Ma
27 [GO] 2022―Sep―14 Transcriptomics, Cheminformatics, and Systems Pharmacology Strategies Unveil the Potential Bioactives to Combat COVID-19 Sivakumar Adarshan, Sakthivel Akassh, Krishnakumar Avinash, Mathivanan Bharathkumar, Pandiyan Muthuramalingam, Hyunsuk Shin, et al. (+4)
28 [GO] 2022―Sep―14 Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals Margarita Villar, José Miguel Urra, Sara Artigas-Jerónimo, Lorena Mazuecos, Marinela Contreras, Rita Vaz-Rodrigues, et al. (+3)
29 [GO] 2022―Sep―13 The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses Beata Pająk, Rafał Zieliński, John Tyler Manning, Stanislava Matejin, Slobodan Paessler, Izabela Fokt, et al. (+2)
30 [GO] 2022―Sep―13 Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach Kailey A. Wyman, Adel S. Girgis, Pragnakiran S. Surapaneni, Jade M. Moore, Noura M. Abo Shama, Sara H. Mahmoud, et al. (+7)
31 [GO] 2022―Sep―08 Variation of Proteolytic Cleavage Sites towards the N-Terminal End of the S2 Subunit of the Novel SARS-CoV-2 Omicron Sublineage BA.2.12.1 Nadine Anna Schilling, Hubert Kalbacher, Timo Burster
32 [GO] 2022―Sep―07 New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture Alexey Sulimov, Ivan Ilin, Danil Kutov, Khidmet Shikhaliev, Dmitriy Shcherbakov, Oleg Pyankov, et al. (+3)
33 [GO] 2022―Sep―01 Deciphering the Potential of Pre and Pro-Vitamin D of Mushrooms against Mpro and PLpro Proteases of COVID-19: An In Silico Approach Abhay Tiwari, Garima Singh, Gourav Choudhir, Mohit Motiwale, Nidhi Joshi, Vasudha Sharma, et al. (+4)
34 [GO] 2022―Aug―31 Preparation and Characterization of Disulfiram and Beta Cyclodextrin Inclusion Complexes for Potential Application in the Treatment of SARS-CoV-2 via Nebulization Ana Maria Pereira, Ayse Kaya, Dan Alves, Niusha Ansari-Fard, Ibrahim Tolaymat, Basel Arafat, Mohammad Najlah
35 [GO] 2022―Aug―25 Assessment of a Computational Approach to Predict Drug Resistance Mutations for HIV, HBV and SARS-CoV-2 Dharmeshkumar Patel, Suzane K. Ono, Leda Bassit, Kiran Verma, Franck Amblard, Raymond F. Schinazi
36 [GO] 2022―Aug―25 Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2 Takashi Tanikawa, Yuka Kiba, James Yu, Kate Hsu, Shinder Chen, Ayako Ishii, et al. (+4)
37 [GO] 2022―Aug―22 The Impact of Severe COVID-19 on Plasma Antioxidants Neven Žarković, Anna Jastrząb, Iwona Jarocka-Karpowicz, Biserka Orehovec, Bruno Baršić, Marko Tarle, et al. (+4)
38 [GO] 2022―Aug―22 SARS-CoV-2 and MERS-CoV Spike Protein Binding Studies Support Stable Mimic of Bound 9-O-Acetylated Sialic Acids Lisa Oh, Ajit Varki, Xi Chen, Lee-Ping Wang
39 [GO] 2022―Aug―22 Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors Mabrouk Horchani, Niels V. Heise, René Csuk, Hichem Ben Jannet, Abdel Halim Harrath, Anis Romdhane
40 [GO] 2022―Aug―17 Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches Shah Faisal, Syed Lal Badshah, Bibi Kubra, Mohamed Sharaf, Abdul-Hamid Emwas, Mariusz Jaremko, Mohnad Abdalla
41 [GO] 2022―Aug―15 In Silico and In Vitro Studies of Alchemilla viridiflora Rothm-Polyphenols’ Potential for Inhibition of SARS-CoV-2 Internalization Relja Suručić, Jelena Radović Selgrad, Tatjana Kundaković-Vasović, Biljana Lazović, Maja Travar, Ljiljana Suručić, Ranko Škrbić
42 [GO] 2022―Aug―12 Investigation of the N-Glycosylation of the SARS-CoV-2 S Protein Contained in VLPs Produced in Nicotiana benthamiana Juliette Balieu, Jae-Wan Jung, Philippe Chan, George P. Lomonossoff, Patrice Lerouge, Muriel Bardor
43 [GO] 2022―Aug―09 The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2 Andrey A. Ivashchenko, Bogdan A. Zagribelnyy, Yan A. Ivanenkov, Ilya A. Ivashchenko, Ruben N. Karapetian, Dmitry V. Kravchenko, et al. (+3)
44 [GO] 2022―Aug―02 Phytochemical Discrimination, Biological Activity and Molecular Docking of Water-Soluble Inhibitors from Saussurea costus Herb against Main Protease of SARS-CoV-2 Hajo Idriss, Babeker Siddig, Pamela González Maldonado, H. M. Elkhair, A. I. Alakhras, Emad M. Abdallah, et al. (+2)
45 [GO] 2022―Aug―01 Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System Graham J. Moore, Harry Ridgway, Konstantinos Kelaidonis, Christos T. Chasapis, Irene Ligielli, Thomas Mavromoustakos, et al. (+2)
46 [GO] 2022―Jul―26 Solanaceae Family Phytochemicals as Inhibitors of 3C-Like Protease of SARS-CoV-2: An In Silico Analysis Raisul Awal Mahmood, Anamul Hasan, Mohammed Rahmatullah, Alok K. Paul, Rownak Jahan, Khoshnur Jannat, et al. (+8)
47 [GO] 2022―Jul―14 A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery Aekkhaluck Intharuksa, Warunya Arunotayanun, Wipawadee Yooin, Panee Sirisa-ard
48 [GO] 2022―Jul―11 In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2 Norah A. Alturki, Mutaib M. Mashraqi, Ahmad Alzamami, Youssef S. Alghamdi, Afaf A. Alharthi, Saeed A. Asiri, et al. (+2)
49 [GO] 2022―Jul―06 Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer Anna Tesei, Michela Cortesi, Martina Bedeschi, Noemi Marino, Giacomo Rossino, Roberta Listro, et al. (+3)
50 [GO] 2022―Jul―05 In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of Nigella sativa and Pimpinella anisum as Potential Inhibitors of 3CL Protease of SARS-CoV-2 Awatif A. Hendi, Promy Virk, Manal A. Awad, Mai Elobeid, Khalid M. O. Ortashi, Meznah M. Alanazi, et al. (+3)
51 [GO] 2022―Jul―05 From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease Matthias Göhl, Linlin Zhang, Haifa El Kilani, Xinyuanyuan Sun, Kaixuan Zhang, Mark Brönstrup, Rolf Hilgenfeld
52 [GO] 2022―Jul―01 In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19 Shuo Wang, Xuexun Fang, Ye Wang
53 [GO] 2022―Jul―01 The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2 Joy Y. Feng, Venice Du Pont, Darius Babusis, Calvin Gordon, Egor Tchesnokov, Jason Perry, et al. (+9)
54 [GO] 2022―Jun―29 K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, Carlotta Siddi, Walter Fratta, Maria Scherma, Paola Fadda
55 [GO] 2022―Jun―23 Design of SARS-CoV-2 Main Protease Inhibitors Using Artificial Intelligence and Molecular Dynamic Simulations Lars Elend, Luise Jacobsen, Tim Cofala, Jonas Prellberg, Thomas Teusch, Oliver Kramer, Ilia A. Solov’yov
56 [GO] 2022―Jun―21 Design of Novel Enantiopure Dispirooxindolopyrrolidine-Piperidones as Promising Candidates toward COVID-19: Asymmetric Synthesis, Crystal Structure and In Silico Studies Amani Toumi, Sarra Boudriga, Yasmine M. Mandour, Ahmed A. Mekki, Michael Knorr, Carsten Strohmann, et al. (+2)
57 [GO] 2022―Jun―21 Graphene Oxide-Sensitized Surface Plasmon Resonance Biosensor of Porcine Reproductive and Respiratory Syndrome Virus Xuemei Liu, Chao Xu, Chunyu Fu, Dongfang Xia, Fuchao Wang, Hongzong Yin, Jun Peng
58 [GO] 2022―Jun―19 Rational Design of Peptides Derived from Odorant-Binding Proteins for SARS-CoV-2-Related Volatile Organic Compounds Recognition Jin Wang, Kenji Sakai, Toshihiko Kiwa
59 [GO] 2022―Jun―17 Implementing Silica Nanoparticles in the Study of the Airborne Transmission of SARS-CoV-2 Robert Hildebrandt, Krystian Skubacz, Izabela Chmielewska, Zdzisław Dyduch, Aleksandra Zgórska, Adam Smoliński
60 [GO] 2022―Jun―16 Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes Patrick Guérin, Nouara Yahi, Fodil Azzaz, Henri Chahinian, Jean-Marc Sabatier, Jacques Fantini
61 [GO] 2022―Jun―15 Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19 Bing Wang, Dmitri Svetlov, Dylan Bartikofsky, Christiane E. Wobus, Irina Artsimovitch
62 [GO] 2022―Jun―15 Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
63 [GO] 2022―Jun―14 The Extracts of Polygonum cuspidatum Root and Rhizome Block the Entry of SARS-CoV-2 Wild-Type and Omicron Pseudotyped Viruses via Inhibition of the S-Protein and 3CL Protease Shengying Lin, Xiaoyang Wang, Roy Wai-Lun Tang, Hung Chun Lee, Ho Hin Chan, Sheyne S. A. Choi, et al. (+5)
64 [GO] 2022―Jun―13 Analytical Performance and Greenness Evaluation of Five Multi-Level Design Models Utilized for Impurity Profiling of Favipiravir, a Promising COVID-19 Antiviral Drug Adel Ehab Ibrahim, Yasmine Ahmed Sharaf, Sami El Deeb, Rania Adel Sayed
65 [GO] 2022―Jun―13 Potential Use of Tea Tree Oil as a Disinfectant Agent against Coronaviruses: A Combined Experimental and Simulation Study Alice Romeo, Federico Iacovelli, Carolina Scagnolari, Mirko Scordio, Federica Frasca, Roberta Condò, et al. (+5)
66 [GO] 2022―Jun―13 Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes Iwona Karwaciak, Kaja Karaś, Anna Sałkowska, Joanna Pastwińska, Marcin Ratajewski
67 [GO] 2022―Jun―13 Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3-b]Pyridine Derivatives Alena L. Stalinskaya, Nadezhda V. Martynenko, Zarina T. Shulgau, Alexandr V. Shustov, Viktoriya V. Keyer, Ivan V. Kulakov
68 [GO] 2022―May―24 Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors Jing Wu, Bo Feng, Li-Xin Gao, Chun Zhang, Jia Li, Da-Jun Xiang, et al. (+2)
69 [GO] 2022―May―09 The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance Bruno S. Lopes, Alfizah Hanafiah, Ramesh Nachimuthu, Saravanan Muthupandian, Zarith Nameyrra Md Nesran, Sandip Patil
70 [GO] 2022―May―04 Conducting the RBD of SARS-CoV-2 Omicron Variant with Phytoconstituents from Euphorbia dendroides to Repudiate the Binding of Spike Glycoprotein Using Computational Molecular Search and Simulation Approach Heba Ali Hassan, Ahmed R. Hassan, Eslam A.R. Mohamed, Ahmad Al-Khdhairawi, Alaa Karkashan, Roba Attar, et al. (+5)
71 [GO] 2022―May―03 Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex Jerome Deval, Zachary A. Gurard-Levin
72 [GO] 2022―Apr―28 The Role of Cannabis sativa L. as a Source of Cannabinoids against Coronavirus 2 (SARS-CoV-2): An In Silico Study to Evaluate Their Activities and ADMET Properties Ahmed E. Altyar, Fadia S. Youssef, Maram M. Kurdi, Renad J. Bifari, Mohamed L. Ashour
73 [GO] 2022―Apr―27 Plant Polysaccharides Modulate Immune Function via the Gut Microbiome and May Have Potential in COVID-19 Therapy Mengsheng Tang, Lu Cheng, Yanan Liu, Zufang Wu, Xin Zhang, Songmei Luo
74 [GO] 2022―Apr―26 Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, Saif M. Alkhaldi, Fayez Nafea Alshammari, Mehnaz Kamal, et al. (+4)
75 [GO] 2022―Apr―25 Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection Jian Li, Guangrui Chen, Zhiyun Meng, Zhuona Wu, Hui Gan, Xiaoxia Zhu, et al. (+5)
76 [GO] 2022―Apr―24 Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, Miguel Viveiros, Celso Cunha
77 [GO] 2022―Apr―24 Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus Alexey Sulimov, Danil Kutov, Ivan Ilin, Yibei Xiao, Sheng Jiang, Vladimir Sulimov
78 [GO] 2022―Apr―21 Docking Analysis of Some Bioactive Compounds from Traditional Plants against SARS-CoV-2 Target Proteins Nourhan M. Abd El-Aziz, Ibrahim Khalifa, Amira M. G. Darwish, Ahmed N. Badr, Huda Aljumayi, El-Sayed Hafez, Mohamed G. Shehata
79 [GO] 2022―Apr―19 Advances in the Development of SARS-CoV-2 Mpro Inhibitors Laura Agost-Beltrán, Sergio de la Hoz-Rodríguez, Lledó Bou-Iserte, Santiago Rodríguez, Adrián Fernández-de-la-Pradilla, Florenci V. González
80 [GO] 2022―Apr―13 The Dysregulation of the Renin-Angiotensin System in COVID-19 Studied by Serum Proteomics: Angiotensinogen Increases with Disease Severity Phil-Robin Tepasse, Richard Vollenberg, Nico Steinebrey, Simone König
81 [GO] 2022―Apr―09 Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing Bandar Hamad Aloufi, Mejdi Snoussi, Abdel Moneim E. Sulieman
82 [GO] 2022―Apr―08 The Importance of Nutraceuticals in COVID-19: What’s the Role of Resveratrol? Elisa Domi, Malvina Hoxha, Entela Kolovani, Domenico Tricarico, Bruno Zappacosta
83 [GO] 2022―Apr―08 Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach Taimoor Khan, Abbas Khan, Jawad Khaliq Ansari, Muzammil Hasan Najmi, Dong-Qing Wei, Khalid Muhammad, Yasir Waheed
84 [GO] 2022―Apr―08 Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor Maurizio Cavani, Walter Arnaldo Riofrío, Marcelino Arciniega
85 [GO] 2022―Apr―04 Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen Yasmine Ahmed Sharaf, Sami El Deeb, Adel Ehab Ibrahim, Ahmed Al-Harrasi, Rania Adel Sayed
86 [GO] 2022―Apr―02 Health-Promoting Properties of Medicinal Mushrooms and Their Bioactive Compounds for the COVID-19 Era-An Appraisal: Do the Pro-Health Claims Measure Up? Jennifer Mary Phillips, Soo Liang Ooi, Sok Cheon Pak
87 [GO] 2022―Apr―01 Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca Yerlan M. Suleimen, Rani A. Jose, Raigul N. Suleimen, Margarita Y. Ishmuratova, Suzanne Toppet, Wim Dehaen, et al. (+4)
88 [GO] 2022―Apr―01 Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs Ibrahim H. Eissa, Mohamed S. Alesawy, Abdulrahman M. Saleh, Eslam B. Elkaeed, Bshra A. Alsfouk, Abdul-Aziz M. M. El-Attar, Ahmed M. Metwaly
89 [GO] 2022―Mar―31 Potential Effects of Ibuprofen, Remdesivir and Omeprazole on Dexamethasone Metabolism in Control Sprague Dawley Male Rat Liver Microsomes (Drugs Often Used Together Alongside COVID-19 Treatment) Amira Hussain, Declan P. Naughton, James Barker
90 [GO] 2022―Mar―30 Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, Diah Kusumawaty, Moon Nyeo Park, Abolghasem Siyadatpanah, et al. (+5)
91 [GO] 2022―Mar―30 Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2 Anthi Petrou, Panagiotis Zagaliotis, Nikoleta F. Theodoroula, George A. Mystridis, Ioannis S. Vizirianakis, Thomas J. Walsh, Athina Geronikaki
92 [GO] 2022―Mar―25 Theoretical Investigation of the Coronavirus SARS-CoV-2 (COVID-19) Infection Mechanism and Selectivity Iga Biskupek, Adam Sieradzan, Cezary Czaplewski, Adam Liwo, Adam Lesner, Artur Giełdoń
93 [GO] 2022―Mar―24 Structure/Function Analysis of Truncated Amino-Terminal ACE2 Peptide Analogs That Bind to SARS-CoV-2 Spike Glycoprotein Robert T. Mackin, J. Vincent Edwards, E. Berk Atuk, Noah Beltrami, Brian D. Condon, Janarthanan Jayawickramarajah, Alfred D. French
94 [GO] 2022―Mar―23 Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases George El-Arif, Shaymaa Khazaal, Antonella Farhat, Julien Harb, Cédric Annweiler, Yingliang Wu, et al. (+5)
95 [GO] 2022―Mar―21 The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites Antony Cheudjeu
96 [GO] 2022―Mar―16 Fullerenes against COVID-19: Repurposing C60 and C70 to Clog the Active Site of SARS-CoV-2 Protease Tainah Dorina Marforio, Edoardo Jun Mattioli, Francesco Zerbetto, Matteo Calvaresi
97 [GO] 2022―Mar―15 Rapid Degradation of SARS-CoV-2 Spike S Protein by A Specific Serine Protease Jiankai Liu, Mujie Kan, Lianzhi Zhang, Yuan Yue, Shaohua Wang, Min Hong, Xinyu Hong
98 [GO] 2022―Mar―09 Screening of Natural Products Inhibitors of SARS-CoV-2 Entry Pamela González-Maldonado, Nelson Alvarenga, Alberto Burgos-Edwards, Ma. Eugenia Flores-Giubi, Javier E. Barúa, Ma. Cristina Romero-Rodríguez, et al. (+5)
99 [GO] 2022―Mar―09 Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method Suwicha Patnin, Arthit Makarasen, Pongsit Vijitphan, Apisara Baicharoen, Apinya Chaivisuthangkura, Mayuso Kuno, Supanna Techasakul
100 [GO] 2022―Mar―09 Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach Jenifer Mallavarpu Ambrose, Malathi Kullappan, Shankargouda Patil, Khalid J. Alzahrani, Hamsa Jameel Banjer, Fadi S. I. Qashqari, et al. (+8)
101 [GO] 2022―Mar―02 The Potential of Dietary Bioactive Compounds against SARS-CoV-2 and COVID-19-Induced Endothelial Dysfunction Jack N. Losso
102 [GO] 2022―Mar―02 Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease Yerlan M. Suleimen, Rani A. Jose, Raigul N. Suleimen, Christoph Arenz, Margarita Y. Ishmuratova, Suzanne Toppet, et al. (+5)
103 [GO] 2022―Feb―17 Biodegradable Nanohybrid Materials as Candidates for Self-Sanitizing Filters Aimed at Protection from SARS-CoV-2 in Public Areas Anton Manakhov, Elizaveta Permyakova, Natalya Sitnikova, Alphiya Tsygankova, Alexander Alekseev, Maria Solomatina, et al. (+11)
104 [GO] 2022―Feb―07 Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs As Inhibitors of SARS-CoV-2 Replication Dorothée Bardiot, Laura Vangeel, Mohamed Koukni, Philippe Arzel, Marleen Zwaagstra, Heyrhyoung Lyoo, et al. (+23)
105 [GO] 2022―Jan―30 Development and Validation of a Novel HPLC Method to Analyse Metabolic Reaction Products Catalysed by the CYP3A2 Isoform: In Vitro Inhibition of CYP3A2 Enzyme Activity by Aspirin (Drugs Often Used Together in COVID-19 Treatment) Amira Hussain, Declan P. Naughton, James Barker
106 [GO] 2022―Jan―28 A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine Lorella Paparo, Maria Antonia Maglio, Maddalena Cortese, Cristina Bruno, Mario Capasso, Erika Punzo, et al. (+8)
107 [GO] 2022―Jan―26 Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex Nitesh Kumawat, Andrejs Tucs, Soumen Bera, Gennady N. Chuev, Marat Valiev, Marina V. Fedotova, et al. (+4)
108 [GO] 2022―Jan―26 Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp) Anandakrishnan Karthic, Veerbhan Kesarwani, Rahul Kunwar Singh, Pavan Kumar Yadav, Navaneet Chaturvedi, Pallavi Chauhan, et al. (+2)
109 [GO] 2022―Jan―21 Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective J. Carlos Menéndez
110 [GO] 2022―Jan―19 Colorimetric and Electrochemical Methods for the Detection of SARS-CoV-2 Main Protease by Peptide-Triggered Assembly of Gold Nanoparticles Yunxiao Feng, Gang Liu, Ming La, Lin Liu
111 [GO] 2022―Jan―18 Nucleotide Analogues Bearing a C2′ or C3′-Stereogenic All-Carbon Quaternary Center as SARS-CoV-2 RdRp Inhibitors Amarender Manchoju, Renaud Zelli, Gang Wang, Carla Eymard, Adrian Oo, Mona Nemer, et al. (+3)
112 [GO] 2022―Jan―14 Can Artemisia herba-alba Be Useful for Managing COVID-19 and Comorbidities? Anamul Hasan, Partha Biswas, Tohmina Afroze Bondhon, Khoshnur Jannat, Tridib K. Paul, Alok K. Paul, et al. (+8)
113 [GO] 2022―Jan―14 Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study Sraa Abu-Melha, Mastoura Mohamed Edrees, Musa A. Said, Sayed M. Riyadh, Nadia S. Al-Kaff, Sobhi M. Gomha
114 [GO] 2022―Jan―07 Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach Trina Ekawati Tallei, Ahmad Akroman Adam, Mona M. Elseehy, Ahmed M. El-Shehawi, Eman A. Mahmoud, Adinda Dwi Tania, et al. (+8)
115 [GO] 2022―Jan―07 Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses Vladislav V. Fomenko, Nadezhda B. Rudometova, Olga I. Yarovaya, Artem D. Rogachev, Anastasia A. Fando, Anna V. Zaykovskaya, et al. (+7)
116 [GO] 2021―Dec―31 Computational Study of SARS-CoV-2 RNA Dependent RNA Polymerase Allosteric Site Inhibition Shah Faisal, Syed Lal Badshah, Bibi Kubra, Mohamed Sharaf, Abdul-Hamid Emwas, Mariusz Jaremko, Mohnad Abdalla
117 [GO] 2021―Dec―27 Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome Magdalena Świądro, Klaudia Ordon, Małgorzata Herman, Dominika Dudek, Renata Wietecha-Posłuszny
118 [GO] 2021―Dec―16 A Dispersion Corrected DFT Investigation of the Inclusion Complexation of Dexamethasone with β-Cyclodextrin and Molecular Docking Study of Its Potential Activity against COVID-19 Youghourta Belhocine, Seyfeddine Rahali, Hamza Allal, Ibtissem Meriem Assaba, Monira Galal Ghoniem, Fatima Adam Mohamed Ali
119 [GO] 2021―Dec―10 Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment Amin Osman Elzupir
120 [GO] 2021―Dec―10 Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
121 [GO] 2021―Dec―09 Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp) Yifei Wu, David Crich, Scott D. Pegan, Lei Lou, Madelyn C. Hansen, Carson Booth, et al. (+5)
122 [GO] 2021―Dec―06 Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design Wei Yu, Xiaomin Wu, Yizhen Zhao, Chun Chen, Zhiwei Yang, Xiaochun Zhang, et al. (+9)
123 [GO] 2021―Dec―01 Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review Md Sultan Mahmud, Mohammad Sorowar Hossain, A. T. M. Faiz Ahmed, Md Zahidul Islam, Md Emdad Sarker, Md Reajul Islam
124 [GO] 2021―Nov―18 The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19 George El-Arif, Antonella Farhat, Shaymaa Khazaal, Cédric Annweiler, Hervé Kovacic, Yingliang Wu, et al. (+4)
125 [GO] 2021―Nov―18 Ultrasensitive Detection of COVID-19 Causative Virus (SARS-CoV-2) Spike Protein Using Laser Induced Graphene Field-Effect Transistor Tian-Rui Cui, Yan-Cong Qiao, Jian-Wei Gao, Chun-Hua Wang, Yu Zhang, Lin Han, et al. (+2)
126 [GO] 2021―Nov―17 Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, Lizdany Flórez-Álvarez, Lina M. Yepes, Maria T. Rugeles, et al. (+3)
127 [GO] 2021―Nov―12 Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63 Monika Horvat, Martina Avbelj, María Beatriz Durán-Alonso, Mihailo Banjanac, Hrvoje Petković, Jernej Iskra
128 [GO] 2021―Nov―10 Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions Priyanka Saha, Subhankar Bose, Amit Kumar Srivastava, Anis Ahmad Chaudhary, Rajiv Lall, Sahdeo Prasad
129 [GO] 2021―Nov―09 Characterization of the Trans-Epithelial Transport of Green Tea (C. sinensis) Catechin Extracts with In Vitro Inhibitory Effect against the SARS-CoV-2 Papain-like Protease Activity Carmela Maria Montone, Sara Elsa Aita, Anna Arnoldi, Anna Laura Capriotti, Chiara Cavaliere, Andrea Cerrato, et al. (+4)
130 [GO] 2021―Nov―02 Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury Pierpaolo Coni, Giuseppina Pichiri, Joanna Izabela Lachowicz, Alberto Ravarino, Francesca Ledda, Daniela Fanni, et al. (+10)
131 [GO] 2021―Nov―02 Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2 Ahmed A. Al-Karmalawy, Mai M. Farid, Ahmed Mostafa, Alia Y. Ragheb, Sara H. Mahmoud, Mahmoud Shehata, et al. (+4)
132 [GO] 2021―Nov―02 Robust Saliva-Based RNA Extraction-Free One-Step Nucleic Acid Amplification Test for Mass SARS-CoV-2 Monitoring Eva Rajh, Tina Šket, Arne Praznik, Petra Sušjan, Alenka Šmid, Dunja Urbančič, et al. (+12)
133 [GO] 2021―Nov―02 In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies Mohamed S. Alesawy, Eslam B. Elkaeed, Aisha A. Alsfouk, Ahmed M. Metwaly, Ibrahim H. Eissa
134 [GO] 2021―Oct―27 A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses Aaya Nassar, Ibrahim M. Ibrahim, Fatma G. Amin, Merna Magdy, Ahmed M. Elgharib, Eman B. Azzam, et al. (+5)
135 [GO] 2021―Oct―15 In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease Vishma Pratap Sur, Madhab Kumar Sen, Katerina Komrskova
136 [GO] 2021―Oct―15 Standardized Extract of Asparagus officinalis Stem Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages Ken Shirato, Jun Takanari, Takako Kizaki
137 [GO] 2021―Oct―14 Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2 Amr El-Demerdash, Afnan Hassan, Tarek Mohamed Abd Abd El-Aziz, James D. Stockand, Reem K. Arafa
138 [GO] 2021―Oct―14 In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine Mahmoud M. Shehata, Sara H. Mahmoud, Mohammad Tarek, Ahmed A. Al-Karmalawy, Amal Mahmoud, Ahmed Mostafa, et al. (+2)
139 [GO] 2021―Oct―13 In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10 Ibrahim H. Eissa, Mohamed M. Khalifa, Eslam B. Elkaeed, Elsayed E. Hafez, Aisha A. Alsfouk, Ahmed M. Metwaly
140 [GO] 2021―Oct―11 Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment Jingjing Li, Dongge Xu, Lingling Wang, Mengyu Zhang, Guohai Zhang, Erguang Li, Susu He
141 [GO] 2021―Oct―09 Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury Lúcio Ricardo Leite Diniz, Hatem A. Elshabrawy, Marilia Trindade de Santana Souza, Allana Brunna Sucupira Duarte, Sabarno Datta, Damião Pergentino de Sousa
142 [GO] 2021―Oct―09 Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs Athanasios A. Panagiotopoulos, Ioannis Karakasiliotis, Danai-Maria Kotzampasi, Marios Dimitriou, George Sourvinos, Marilena Kampa, et al. (+3)
143 [GO] 2021―Oct―09 l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells Luca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, et al. (+10)
144 [GO] 2021―Sep―28 Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19 Mohd. Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Saleh I. Alaqel, Mohammed Kanan Alshammari, et al. (+8)
145 [GO] 2021―Sep―28 Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19 Roberta Bernini, Francesca Velotti
146 [GO] 2021―Sep―28 Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors Arun K. Ghosh, Dana Shahabi, Monika Yadav, Satish Kovela, Brandon J. Anson, Emma K. Lendy, et al. (+7)
147 [GO] 2021―Sep―22 In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2 Seyyed Sasan Mousavi, Akbar Karami, Tahereh Movahhed Haghighi, Sefren Geiner Tumilaar, Rinaldi Idroes, Shafi Mahmud, et al. (+5)
148 [GO] 2021―Sep―13 The Influence of Propolis on Dental Plaque Reduction and the Correlation between Dental Plaque and Severity of COVID-19 Complications-A Literature Review Anna Kurek-Górecka, Karolina Walczyńska-Dragon, Rafael Felitti, Aleksandra Nitecka-Buchta, Stefan Baron, Paweł Olczyk
149 [GO] 2021―Sep―08 Inactivation Activities of Ozonated Water, Slightly Acidic Electrolyzed Water and Ethanol against SARS-CoV-2 Yohei Takeda, Dulamjav Jamsransuren, Yoshimasa Makita, Akihiro Kaneko, Sachiko Matsuda, Haruko Ogawa, Hourei Oh
150 [GO] 2021―Sep―07 A Review of the Health Protective Effects of Phenolic Acids against a Range of Severe Pathologic Conditions (Including Coronavirus-Based Infections) Sotirios Kiokias, Vassiliki Oreopoulou
151 [GO] 2021―Aug―31 GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-Like Protease Inhibitors from Zingiber officinale Roscoe Muhammad Sulaiman Zubair, Saipul Maulana, Agustinus Widodo, Ramadanil Pitopang, Muhammad Arba, Maywan Hariono
152 [GO] 2021―Aug―25 Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations Devashan Naidoo, Pallab Kar, Ayan Roy, Taurai Mutanda, Joseph Bwapwa, Arnab Sen, Akash Anandraj
153 [GO] 2021―Aug―18 An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations Amin Islam, Mohammed Sheraz Bashir, Kevin Joyce, Harunor Rashid, Ismail Laher, Shereen Elshazly
154 [GO] 2021―Aug―18 Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD Thamer A. Bouback, Sushil Pokhrel, Abdulaziz Albeshri, Amal Mohammed Aljohani, Abdus Samad, Rahat Alam, et al. (+6)
155 [GO] 2021―Aug―12 Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors Marjorie C. L. C. Freire, Gabriela D. Noske, Natália V. Bitencourt, Paulo R. S. Sanches, Norival A. Santos-Filho, Victor O. Gawriljuk, et al. (+14)
156 [GO] 2021―Aug―09 Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins Yohei Takeda, Kyohei Tamura, Dulamjav Jamsransuren, Sachiko Matsuda, Haruko Ogawa
157 [GO] 2021―Jul―06 Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2 Susana A. Llivisaca-Contreras, Jaime Naranjo-Morán, Andrea Pino-Acosta, Luc Pieters, Wim Vanden Berghe, Patricia Manzano, et al. (+3)
158 [GO] 2021―Jun―29 Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19 Ying-Qi Wang, Qing-Sheng Li, Xin-Qiang Zheng, Jian-Liang Lu, Yue-Rong Liang
159 [GO] 2021―Jun―28 Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, Roja Rahimi
160 [GO] 2021―Jun―28 Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes Nadezhda Palko, Maria Grishina, Vladimir Potemkin
161 [GO] 2021―Jun―25 Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach Luis Daniel Goyzueta-Mamani, Haruna Luz Barazorda-Ccahuana, Karel Mena-Ulecia, Miguel Angel Chávez-Fumagalli
162 [GO] 2021―Jun―24 A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov Rambod Abiri, Hazandy Abdul-Hamid, Oksana Sytar, Ramin Abiri, Eduardo Bezerra de Almeida, Surender K. Sharma, et al. (+3)
163 [GO] 2021―Jun―23 Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma Mohammad Hailat, Israa Al-Ani, Mohammed Hamad, Zainab Zakareia, Wael Abu Dayyih
164 [GO] 2021―Jun―21 Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization Ayman Abo Elmaaty, Mohammed I. A. Hamed, Muhammad I. Ismail, Eslam B. Elkaeed, Hamada S. Abulkhair, Muhammad Khattab, Ahmed A. Al-Karmalawy
165 [GO] 2021―Jun―21 Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study Nourhan Hisham Shady, Alaa M. Hayallah, Mamdouh F. A. Mohamed, Mohammed M. Ghoneim, Garri Chilingaryan, Mohammad M. Al-Sanea, et al. (+3)
166 [GO] 2021―Jun―11 Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins Eriko Ohgitani, Masaharu Shin-Ya, Masaki Ichitani, Makoto Kobayashi, Takanobu Takihara, Masaya Kawamoto, et al. (+2)
167 [GO] 2021―Jun―09 A Multidisciplinary Approach to Coronavirus Disease (COVID-19) Aliye Gediz Gediz Erturk, Arzu Sahin, Ebru Bati Bati Ay, Emel Pelit, Emine Bagdatli, Irem Kulu, et al. (+5)
168 [GO] 2021―Jun―09 Transport of Aerosols in Underground Mine Workings in Terms of SARS-CoV-2 Virus Threat Krystian Skubacz, Robert Hildebrandt, Aleksandra Zgórska, Zdzisław Dyduch, Krzysztof Samolej, Adam Smolinski
169 [GO] 2021―Jun―07 Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against SARS-CoV-2 Denis O. Shatalov, Stanislav A. Kedik, Ivan S. Ivanov, Anna V. Aydakova, Diana A. Akhmedova, Dmitrii S. Minenkov, et al. (+5)
170 [GO] 2021―Jun―07 Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues Vasiliki Daikopoulou, Panagiotis Apostolou, Sofia Mourati, Ioanna Vlachou, Maria Gougousi, Ioannis Papasotiriou
171 [GO] 2021―Jun―02 Anti-Inflammatory, Antiallergic, and COVID-19 Main Protease (Mpro) Inhibitory Activities of Butenolides from a Marine-Derived Fungus Aspergillus terreus Ibrahim Seyda Uras, Sherif S. Ebada, Michal Korinek, Amgad Albohy, Basma S. Abdulrazik, Yi-Hsuan Wang, et al. (+5)
172 [GO] 2021―May―27 Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries Alon Ben David, Eran Diamant, Eyal Dor, Ada Barnea, Niva Natan, Lilach Levin, et al. (+5)
173 [GO] 2021―May―18 Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants Marko Jukič, Blaž Škrlj, Gašper Tomšič, Sebastian Pleško, Črtomir Podlipnik, Urban Bren
174 [GO] 2021―May―14 Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates Sajad Fakhri, Zeinab Nouri, Seyed Zachariah Moradi, Esra Küpeli Akkol, Sana Piri, Eduardo Sobarzo-Sánchez, et al. (+2)
175 [GO] 2021―May―11 Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability Nikola Gligorijević, Dragana Stanić-Vučinić, Mirjana Radomirović, Marija Stojadinović, Urmila Khulal, Olgica Nedić, Tanja Ćirković Veličković
176 [GO] 2021―May―10 In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Mohamed S. Alesawy, Abdallah E. Abdallah, Mohammed S. Taghour, Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly
177 [GO] 2021―Apr―30 The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19 Tatyana A. Kuznetsova, Boris G. Andryukov, Ilona D. Makarenkova, Tatyana S. Zaporozhets, Natalya N. Besednova, Ludmila N. Fedyanina, et al. (+2)
178 [GO] 2021―Apr―30 Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis Federico Vittorio Rossi, Dario Gentili, Enrico Marcantoni
179 [GO] 2021―Apr―30 D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect Romina Oliva, Abdul Rajjak Shaikh, Andrea Petta, Anna Vangone, Luigi Cavallo
180 [GO] 2021―Apr―29 Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus Olivier Terrier, Sébastien Dilly, Andrés Pizzorno, Dominika Chalupska, Jana Humpolickova, Evžen Bouřa, et al. (+10)
181 [GO] 2021―Apr―29 In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells Sherif Aly El-Kafrawy, Sayed Sartaj Sohrab, Zeenat Mirza, Ahmed M. Hassan, Fatima Alsaqaf, Esam Ibraheem Azhar
182 [GO] 2021―Apr―20 An Effective MM/GBSA Protocol for Absolute Binding Free Energy Calculations: A Case Study on SARS-CoV-2 Spike Protein and the Human ACE2 Receptor Negin Forouzesh, Nikita Mishra
183 [GO] 2021―Apr―12 Molecular Dynamic Simulation Search for Possible Amphiphilic Drug Discovery for Covid-19 Umer Daood, Divya Gopinath, Malikarjuna Rao Pichika, Kit-Kay Mak, Liang Lin Seow
184 [GO] 2021―Apr―12 Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study Shafi Mahmud, Gobindo Kumar Paul, Mirola Afroze, Shirmin Islam, Swagota Briti Ray Gupt, Mamudul Hasan Razu, et al. (+9)
185 [GO] 2021―Apr―09 Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2 Md. Asraful Alam, Roberto Parra-Saldivar, Muhammad Bilal, Chowdhury Alfi Afroze, Md. Nasir Ahmed, Hafiz M.N. Iqbal, Jingliang Xu
186 [GO] 2021―Apr―09 Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor Norbert Odolczyk, Ewa Marzec, Maria Winiewska-Szajewska, Jarosław Poznański, Piotr Zielenkiewicz
187 [GO] 2021―Apr―05 In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Tarik A. Mohamed, Mohamed A. M. Atia, Montaser A. M. Al-Hammady, Khlood A. A. Abdeljawaad, et al. (+8)
188 [GO] 2021―Mar―30 The Inhibitory Effects of Plant Derivate Polyphenols on the Main Protease of SARS Coronavirus 2 and Their Structure-Activity Relationship Thi Thanh Hanh Nguyen, Jong-Hyun Jung, Min-Kyu Kim, Sangyong Lim, Jae-Myoung Choi, Byoungsang Chung, et al. (+2)
189 [GO] 2021―Mar―29 Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform Kaushik Chakravarty, Victor G. Antontsev, Maksim Khotimchenko, Nilesh Gupta, Aditya Jagarapu, Yogesh Bundey, et al. (+3)
190 [GO] 2021―Mar―22 Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities Salar Hafez Ghoran, Mohamed El-Shazly, Nazim Sekeroglu, Anake Kijjoa
191 [GO] 2021―Mar―22 Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2 Arumugam Vijaya Anand, Balasubramanian Balamuralikrishnan, Mohandass Kaviya, Kathirvel Bharathi, Aluru Parithathvi, Meyyazhagan Arun, et al. (+8)
192 [GO] 2021―Mar―22 Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development Mohamed E. Abouelela, Hamdy K. Assaf, Reda A. Abdelhamid, Ehab S. Elkhyat, Ahmed M. Sayed, Tomasz Oszako, et al. (+3)
193 [GO] 2021―Mar―12 Receptor-Based Pharmacophore Modeling in the Search for Natural Products for Covid-19 Mpro Mohd Saeed, Amir Saeed, Md. Jahoor Alam, Mousa Alreshidi
194 [GO] 2021―Mar―08 Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme Sajjad Ahmad, Yasir Waheed, Saba Ismail, Saadia Bhatti, Sumra Wajid Abbasi, Khalid Muhammad
195 [GO] 2021―Mar―05 SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome Anna Maria Sardanelli, Camilla Isgrò, Luigi Leonardo Palese
196 [GO] 2021―Feb―26 Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies Amira Mohammed Ali, Hiroshi Kunugi
197 [GO] 2021―Feb―24 EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection Mukesh Chourasia, Purushotham Reddy Koppula, Aruna Battu, Madhu M. Ouseph, Anil K. Singh
198 [GO] 2021―Feb―23 Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach Christian R. Gomez, Ingrid Espinoza, Fazlay S. Faruke, Md. Mahbub Hasan, Khondaker Miraz Rahman, Larry A. Walker, Ilias Muhammad
199 [GO] 2021―Feb―22 Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease Roxanna Hajbabaie, Matthew T. Harper, Taufiq Rahman
200 [GO] 2021―Feb―19 In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2 Sebastián A. Cuesta, José R. Mora, Edgar A. Márquez
201 [GO] 2021―Feb―14 Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders Roberta Giordo, Angelo Zinellu, Ali Hussein Eid, Gianfranco Pintus
202 [GO] 2021―Feb―14 Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses Nicola Borbone, Gennaro Piccialli, Giovanni Nicola Roviello, Giorgia Oliviero
203 [GO] 2021―Feb―12 Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors Poonam Kalhotra, Veera C.S.R. Chittepu, Guillermo Osorio-Revilla, Tzayhri Gallardo-Velazquez
204 [GO] 2021―Feb―04 Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease Candida Manelfi, Jonas Gossen, Silvia Gervasoni, Carmine Talarico, Simone Albani, Benjamin Joseph Philipp, et al. (+5)
205 [GO] 2021―Jan―31 COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds Oksana Sytar, Marian Brestic, Shokoofeh Hajihashemi, Milan Skalicky, Jan Kubeš, Laura Lamilla-Tamayo, et al. (+3)
206 [GO] 2021―Jan―30 In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches Alonso Vivar-Sierra, María José Araiza-Macías, José Patricio Hernández-Contreras, Arely Vergara-Castañeda, Gabriela Ramírez-Vélez, Rodolfo Pinto-Almazán, et al. (+2)
207 [GO] 2021―Jan―28 Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism Riadh Badraoui, Mohd Adnan, Fevzi Bardakci, Mousa M. Alreshidi
208 [GO] 2021―Jan―28 Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2 Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Sajjad Ahmad, Guanglin Li
209 [GO] 2021―Jan―26 Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets Isabella Romeo, Francesco Mesiti, Antonio Lupia, Stefano Alcaro
210 [GO] 2021―Jan―25 From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy John Matsoukas, Vasso Apostolopoulos, Anthony Zulli, Graham Moore, Konstantinos Kelaidonis, Kalliopi Moschovou, Thomas Mavromoustakos
211 [GO] 2021―Jan―19 Natural and Nature-Derived Products Targeting Human Coronaviruses Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, Michael N. Alexis, Alexios-Leandros Skaltsounis
212 [GO] 2020―Dec―31 The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities Xiao Cong Pang, Han Xu Zhang, Zhi Zhang, Suguro Rinkiko, Yi Min Cui, Yi Zhun Zhu
213 [GO] 2020―Dec―29 Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity Leonardo Lupacchini, Fabrizio Maggi, Carlo Tomino, Chiara De Dominicis, Cristiana Mollinari, Massimo Fini, et al. (+3)
214 [GO] 2020―Dec―25 Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology Zhi-Ling Zhu, Xiao-Dan Qiu, Shuo Wu, Yi-Tong Liu, Ting Zhao, Zhong-Hao Sun, et al. (+2)
215 [GO] 2020―Dec―23 COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far Mujeeb Khan, Syed F. Adil, Hamad Z. Alkhathlan, Muhammad N. Tahir, Sadia Saif, Merajuddin Khan, Shams T. Khan
216 [GO] 2020―Dec―23 Anomaly Identification during Polymerase Chain Reaction for Detecting SARS-CoV-2 Using Artificial Intelligence Trained from Simulated Data Reynaldo Villarreal-González, Antonio J. Acosta-Hoyos, Jaime A. Garzon-Ochoa, Nataly J. Galán-Freyle, Paola Amar-Sepúlveda, Leonardo C. Pacheco-Londoño
217 [GO] 2020―Dec―17 Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment Bwalya A. Witika, Pedzisai A. Makoni, Larry L. Mweetwa, Pascal V. Ntemi, Melissa T. R. Chikukwa, Scott K. Matafwali, et al. (+4)
218 [GO] 2020―Dec―15 Pandemic-Driven Development of a Medical-Grade, Economic and Decentralized Applicable Polyolefin Filament for Additive Fused Filament Fabrication Felix Burkhardt, Carl G. Schirmeister, Christian Wesemann, Massimo Nutini, Stefano Pieralli, Erik H. Licht, et al. (+4)
219 [GO] 2020―Dec―14 Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction Mohammed Sikander, Shabnam Malik, Anyssa Rodriguez, Murali M. Yallapu, Acharan S. Narula, Sanjaya K. Satapathy, et al. (+3)
220 [GO] 2020―Dec―14 Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients? Giovanna Giovinazzo, Carmela Gerardi, Caterina Uberti-Foppa, Lucia Lopalco
221 [GO] 2020―Dec―14 Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features Sk. Sarif Hassan, Shinjini Ghosh, Diksha Attrish, Pabitra Pal Choudhury, Alaa A. A. Aljabali, Bruce D. Uhal, et al. (+18)
222 [GO] 2020―Dec―11 The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients Alessandro G. Fois, Panagiotis Paliogiannis, Valentina Scano, Stefania Cau, Sergio Babudieri, Roberto Perra, et al. (+9)
223 [GO] 2020―Dec―11 Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury Lúcio Ricardo Leite Diniz, Marilia Trindade de Santana Souza, Allana Brunna Sucupira Duarte, Damião Pergentino de Sousa
224 [GO] 2020―Dec―11 Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CLpro) Non-Covalent Small-Molecule Inhibitors Marko Jukič, Dušanka Janežič, Urban Bren
225 [GO] 2020―Dec―11 Molecular Docking Study on Several Benzoic Acid Derivatives against SARS-CoV-2 Amalia Stefaniu, Lucia Pirvu, Bujor Albu, Lucia Pintilie
226 [GO] 2020―Dec―02 Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach Mohd Saeed, Amir Saeed, Md Jahoor Alam, Mousa Alreshidi
227 [GO] 2020―Nov―30 Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein Loai M. Saadah, Ghina’a I. Abu Deiab, Qosay Al-Balas, Iman A. Basheti
228 [GO] 2020―Nov―30 Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study Gema Lizbeth Ramírez-Salinas, Marlet Martínez-Archundia, José Correa-Basurto, Jazmín García-Machorro
229 [GO] 2020―Nov―26 In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2 Yamil Liscano, Jose Oñate-Garzón, Iván Darío Ocampo-Ibáñez
230 [GO] 2020―Nov―24 Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach Teresa L. Augustin, Roxanna Hajbabaie, Matthew T. Harper, Taufiq Rahman
231 [GO] 2020―Nov―24 Alkaloids: Therapeutic Potential against Human Coronaviruses Burtram C. Fielding, Carlos da Silva Maia Bezerra Filho, Nasser S. M. Ismail, Damião Pergentino de Sousa
232 [GO] 2020―Nov―18 A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2 Cecy R Xi, Arianna Di Fazio, Naveed Ahmed Nadvi, Karishma Patel, Michelle Sui Wen Xiang, Hui Emma Zhang, et al. (+12)
233 [GO] 2020―Nov―17 The Role of Vitamin C, Vitamin D, and Selenium in Immune System against COVID-19 Minkyung Bae, Hyeyoung Kim
234 [GO] 2020―Nov―09 Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease Eduardo Tejera, Cristian R. Munteanu, Andrés López-Cortés, Alejandro Cabrera-Andrade, Yunierkis Pérez-Castillo
235 [GO] 2020―Nov―03 Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation Acharya Balkrishna, Siva Kumar Solleti, Sudeep Verma, Anurag Varshney
236 [GO] 2020―Nov―03 Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2 Ahmed Rakib, Saad Ahmed Sami, Md. Ashiqul Islam, Shahriar Ahmed, Farhana Binta Faiz, Bibi Humayra Khanam, et al. (+6)
237 [GO] 2020―Nov―01 In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2 Mathieu Gendrot, Julien Andreani, Priscilla Jardot, Sébastien Hutter, Océane Delandre, Manon Boxberger, et al. (+8)
238 [GO] 2020―Oct―30 Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Kamran Sattar, Suhana Ahmad, Mohd Zulkifli Mustafa, Marcelo De Carvalho Bittencourt, Rohimah Mohamud
239 [GO] 2020―Oct―30 Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies Safaa M. Kishk, Rania M. Kishk, Asmaa S. A. Yassen, Mohamed S. Nafie, Nader A. Nemr, Gamal ElMasry, et al. (+2)
240 [GO] 2020―Oct―17 Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives Camilo Zamora-Ledezma, David F. Clavijo C., Ernesto Medina, Federico Sinche, Nelson Santiago Vispo, Si Amar Dahoumane, Frank Alexis
241 [GO] 2020―Oct―17 High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor Alistair S. Brown, David F. Ackerley, Mark J. Calcott
242 [GO] 2020―Oct―17 Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein-Human ACE2 Receptor Interface Wojciech Płonka, Agata Paneth, Piotr Paneth
243 [GO] 2020―Oct―17 Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study Rajveer Singh, Anupam Gautam, Shivani Chandel, Arijit Ghosh, Dhritiman Dey, Syamal Roy, et al. (+2)
244 [GO] 2020―Oct―07 Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro) Sraa Abu-Melha, Mastoura M. Edrees, Sayed M. Riyadh, Mohamad R. Abdelaziz, Abdo A. Elfiky, Sobhi M. Gomha
245 [GO] 2020―Sep―25 Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19 Dun-Xian Tan, Ruediger Hardeland
246 [GO] 2020―Sep―24 Peptides: Prospects for Use in the Treatment of COVID-19 Vladimir Khavinson, Natalia Linkova, Anastasiia Dyatlova, Boris Kuznik, Roman Umnov
247 [GO] 2020―Sep―11 Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction Danuta Witkowska
248 [GO] 2020―Sep―08 Polyphenols vs. Coronaviruses: How Far Has Research Moved Forward? Simona Piccolella, Giuseppina Crescente, Shadab Faramarzi, Marialuisa Formato, Maria Tommasina Pecoraro, Severina Pacifico
249 [GO] 2020―Sep―07 The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents Gustavo R. Villas-Boas, Vanessa C. Rescia, Marina M. Paes, Stefânia N. Lavorato, Manoel F. de Magalhães-Filho, Mila S. Cunha, et al. (+21)
250 [GO] 2020―Aug―28 Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19 Ahmed Rakib, Arkajyoti Paul, Md. Nazim Uddin Chy, Saad Ahmed Sami, Sumit Kumar Baral, Mohuya Majumder, et al. (+8)
251 [GO] 2020―Aug―24 In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection R.P. Vivek-Ananth, Abhijit Rana, Nithin Rajan, Himansu S. Biswal, Areejit Samal
252 [GO] 2020―Aug―24 Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method Milan Sencanski, Vladimir Perovic, Snezana B. Pajovic, Miroslav Adzic, Slobodan Paessler, Sanja Glisic
253 [GO] 2020―Aug―17 Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study Stefania Mazzini, Loana Musso, Sabrina Dallavalle, Roberto Artali
254 [GO] 2020―Jul―30 Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections Daniel P. Otto, Melgardt M. de Villiers
255 [GO] 2020―Jul―22 High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2 Olujide O. Olubiyi, Maryam Olagunju, Monika Keutmann, Jennifer Loschwitz, Birgit Strodel
256 [GO] 2020―Jun―30 Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1 Olga Tarasova, Sergey Ivanov, Dmitry A. Filimonov, Vladimir Poroikov
257 [GO] 2020―Jun―16 Potential of Flavonoid-Inspired Phytomedicines against COVID-19 Wilfred Ngwa, Rajiv Kumar, Daryl Thompson, William Lyerly, Roscoe Moore, Terry-Elinor Reid, et al. (+2)
258 [GO] 2020―Jun―03 In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus Phaedra Eleftheriou, Dionysia Amanatidou, Anthi Petrou, Athina Geronikaki
259 [GO] 2020―May―22 Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming Elisa Barile, Carlo Baggio, Luca Gambini, Sergey A. Shiryaev, Alex Y. Strongin and Maurizio Pellecchia
260 [GO] 2020―May―20 Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E) Keykavous Parang, Naglaa Salem El-Sayed, Assad J. Kazeminy, Rakesh K. Tiwari
261 [GO] 2020―May―12 Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) Noor Rahman, Zarrin Basharat, Muhammad Yousuf, Giuseppe Castaldo, Luca Rastrelli, Haroon Khan
262 [GO] 2020―Apr―29 Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease Carmen Ciavarella, Ilenia Motta, Sabrina Valente, Gianandrea Pasquinelli
263 [GO] 2020―Apr―21 Advances on Antiviral Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract Infections in the Spotlight Inès Thabti, Quentin Albert, Stéphanie Philippot, François Dupire, Brenda Westerhuis, Stéphane Fontanay, et al. (+5)
264 [GO] 2020―Apr―16 COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help Giovanni Lentini, Maria Maddalena Cavalluzzi, Solomon Habtemariam
265 [GO] 2020―Apr―15 Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses Nakarin Suwannarach, Jaturong Kumla, Kanaporn Sujarit, Thanawat Pattananandecha, Chalermpong Saenjum, Saisamorn Lumyong
 [1] 

265 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec